STOCK TITAN

Nkarta Announces February and March 2021 Investor Conference Schedule

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Nkarta, Inc. (Nasdaq: NKTX) has announced its participation in several upcoming investor conferences, highlighting its focus on advancing NK cell therapies for cancer treatment. The events include the SVB Leerink 10th Annual Global Healthcare Conference on February 26, 2021, featuring a fireside chat at 1:40 p.m. ET, and the Cowen 41st Annual Health Care Conference on March 3-4, 2021, with no presentation scheduled. Additionally, Nkarta will present at the Barclays Global Healthcare Conference on March 11, 2021, at 10:20 a.m. ET. Live webcasts of these presentations will be available on their website.

Positive
  • None.
Negative
  • None.

SOUTH SAN FRANCISCO, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at these upcoming investor conferences:

SVB Leerink 10th Annual Global Healthcare Conference
February 26, 2021
Fireside chat presentation: 1:40 p.m. ET

Cowen 41st Annual Health Care Conference
March 3-4, 2021
No presentation

Barclays Global Healthcare Conference
March 11, 2021
Fireside chat presentation: 10:20 a.m. ET

Live audio webcasts of the presentations will be available on the Investors section of Nkarta’s website, www.nkartatx.com. Replays of the webcasts will be archived on the website for approximately four weeks.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, which are engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit the company’s website at www.nkartatx.com.

Nkarta Media/Investor Contact:
Greg Mann
Nkarta, Inc.
gmann@nkartatx.com


FAQ

What conferences is Nkarta participating in February 2021?

Nkarta is participating in the SVB Leerink 10th Annual Global Healthcare Conference on February 26, 2021.

When will Nkarta present at the Barclays Global Healthcare Conference?

Nkarta will present at the Barclays Global Healthcare Conference on March 11, 2021, at 10:20 a.m. ET.

Is there a webcast available for Nkarta's investor presentations?

Yes, live audio webcasts of the presentations will be available on Nkarta's website.

What is Nkarta developing?

Nkarta is developing engineered natural killer (NK) cell therapies to treat cancer.

When is the Cowen 41st Annual Health Care Conference?

The Cowen 41st Annual Health Care Conference will take place on March 3-4, 2021.

Nkarta, Inc.

NASDAQ:NKTX

NKTX Rankings

NKTX Latest News

NKTX Stock Data

171.48M
65.43M
4.87%
98.82%
13.56%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SOUTH SAN FRANCISCO